KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
AcquisitionsAmortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsCash from RestructuringChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in IntangiblesChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Dividends Paid - CommonExchange Rate EffectFree Cash FlowGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet IncomeOther Working Capital ChangesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Resmed (RMD) Exchange Rate Effect (2016 - 2025)

Resmed (RMD) has disclosed Exchange Rate Effect for 17 consecutive years, with $2.8 million as the latest value for Q4 2025.

  • For the quarter ending Q4 2025, Exchange Rate Effect rose 109.6% year-over-year to $2.8 million, compared with a TTM value of $46.2 million through Dec 2025, up 301.8%, and an annual FY2025 reading of $25.8 million, up 1600.81% over the prior year.
  • Exchange Rate Effect was $2.8 million for Q4 2025 at Resmed, up from -$71000.0 in the prior quarter.
  • Across five years, Exchange Rate Effect topped out at $35.6 million in Q2 2025 and bottomed at -$28.8 million in Q4 2024.
  • Average Exchange Rate Effect over 5 years is $303500.0, with a median of -$140000.0 recorded in 2023.
  • The sharpest move saw Exchange Rate Effect plummeted 4437.61% in 2022, then soared 27475.97% in 2025.
  • Year by year, Exchange Rate Effect stood at -$270000.0 in 2021, then soared by 4140.74% to $10.9 million in 2022, then fell by 22.86% to $8.4 million in 2023, then crashed by 442.32% to -$28.8 million in 2024, then surged by 109.6% to $2.8 million in 2025.
  • Business Quant data shows Exchange Rate Effect for RMD at $2.8 million in Q4 2025, -$71000.0 in Q3 2025, and $35.6 million in Q2 2025.